ADIL
Price
$0.34
Change
+$0.11 (+47.83%)
Updated
Jun 26, 12:53 PM (EDT)
Capitalization
3.88M
GDTC
Price
$2.30
Change
-$0.04 (-1.71%)
Updated
Jun 26, 12:54 PM (EDT)
Capitalization
27M
141 days until earnings call
Interact to see
Advertisement

ADIL vs GDTC

Header iconADIL vs GDTC Comparison
Open Charts ADIL vs GDTCBanner chart's image
Adial Pharmaceuticals
Price$0.34
Change+$0.11 (+47.83%)
Volume$55.04K
Capitalization3.88M
CytoMed Therapeutics
Price$2.30
Change-$0.04 (-1.71%)
Volume$900
Capitalization27M
ADIL vs GDTC Comparison Chart in %
Loading...
ADIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADIL vs. GDTC commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADIL is a Hold and GDTC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (ADIL: $0.25 vs. GDTC: $2.34)
Brand notoriety: ADIL and GDTC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADIL: 885% vs. GDTC: 34%
Market capitalization -- ADIL: $3.88M vs. GDTC: $27M
ADIL [@Biotechnology] is valued at $3.88M. GDTC’s [@Biotechnology] market capitalization is $27M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADIL’s FA Score shows that 1 FA rating(s) are green whileGDTC’s FA Score has 0 green FA rating(s).

  • ADIL’s FA Score: 1 green, 4 red.
  • GDTC’s FA Score: 0 green, 5 red.
According to our system of comparison, ADIL is a better buy in the long-term than GDTC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADIL’s TA Score shows that 4 TA indicator(s) are bullish.

  • ADIL’s TA Score: 4 bullish, 6 bearish.

Price Growth

ADIL (@Biotechnology) experienced а +2.93% price change this week, while GDTC (@Biotechnology) price change was +0.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.78%. For the same industry, the average monthly price growth was +31.36%, and the average quarterly price growth was +15.04%.

Reported Earning Dates

ADIL is expected to report earnings on May 14, 2025.

GDTC is expected to report earnings on Nov 14, 2025.

Industries' Descriptions

@Biotechnology (+1.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GDTC($27M) has a higher market cap than ADIL($3.88M). GDTC YTD gains are higher at: -31.176 vs. ADIL (-75.644).
ADILGDTCADIL / GDTC
Capitalization3.88M27M14%
EBITDA-8.71MN/A-
Gain YTD-75.644-31.176243%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash2.37MN/A-
Total Debt194KN/A-
FUNDAMENTALS RATINGS
ADIL: Fundamental Ratings
ADIL
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
57
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADIL
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ADIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CDNA19.110.23
+1.22%
CareDx
SPRC0.32N/A
+0.76%
SciSparc Ltd
FMS27.73-0.07
-0.25%
Fresenius Medical Care AG
AGYS114.84-0.33
-0.29%
Agilysys
FNWD27.56-0.59
-2.10%
Finward Bancorp

ADIL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADIL has been loosely correlated with SYRE. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ADIL jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADIL
1D Price
Change %
ADIL100%
+7.28%
SYRE - ADIL
39%
Loosely correlated
+2.01%
VANI - ADIL
37%
Loosely correlated
+2.36%
VTVT - ADIL
29%
Poorly correlated
+3.04%
BPMUF - ADIL
28%
Poorly correlated
N/A
GDTC - ADIL
27%
Poorly correlated
+0.06%
More

GDTC and

Correlation & Price change

A.I.dvisor tells us that GDTC and CYCN have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GDTC and CYCN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GDTC
1D Price
Change %
GDTC100%
+0.06%
CYCN - GDTC
30%
Poorly correlated
-0.84%
CVKD - GDTC
29%
Poorly correlated
-7.92%
ADIL - GDTC
27%
Poorly correlated
+7.28%
GRCE - GDTC
27%
Poorly correlated
-1.33%
QSI - GDTC
26%
Poorly correlated
+7.45%
More